Prof. Jacob Schachter's received his MD in 1976 from the Hebrew University, Hadassah Medical Center, Jerusalem, and was recognized as a certified specialist in Oncology in 1987. He is Professor and Head of the Oncology Department in Tel-Aviv University Medical School, and director of the Ella Lemelbaum Institute for Immuno-Oncology and Skin Cancer at the Sheba Medical Center in Israel.
He published over 100 original articles in peer-reviewed journals and chapters in books on the subject of melanoma and tumor immunology and presented his work in many world-leading scientific meetings. His current medical and scientific work is concentrated on adoptive immunotherapy of melanoma patients using Tumor-Infiltrating Lymphocytes (TIL) Technology and in the clinical development of modern immunotherapy technologies including check-points inhibitors.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)